Animal Model Market Size to Reach USD 4.2 billion by 2030 Share and Statistics

The SNS Insider report indicates that the Animal Model Market was valued at USD 2.2 billion in 2022, and is expected to reach market size of USD 4.2 billion by 2030, with a compound annual growth rate (CAGR) of 6.9% expected over the forecast period from 2023 to 2030.

Based on SNS Insider's research, according to the European Federation of Pharmaceutical Industries and Associations, there are around US$ 852 million in global revenue from pharmaceuticals.

Get sample PDF Animal Model Market Report @ https://www.snsinsider.com/sample-request/3789

The major key players In Animal Model Market

→Charles River Laboratories,

→The Jackson Laboratory,

→genOway,

→Taconic Biosciences,

→Janvier Labs,

→Harbour BioMed,

→Crown Bioscience,

→Inotiv, BIOCYTOGEN,

→BioSpherix,

→and Others.

Animal Model Market Report Scope -

Currently, there is a growing demand for personalised medicines throughout the world. This, in confluence with a rising prevalence of genetic disorders, such as down syndrome, Crohn's disease, breast cancer, and hemophilia, represents one of the key factors positively influencing the utilization of animal models in the pre-clinical development of drugs by researchers. In addition, they are being used for medical research, toxicology, physiology, cancer studies, neural sciences, genetics and xenotransplantation all over the world.

Animal Model Market Opportunities-

Due to unexplored, expanding regions, increased healthcare infrastructure, and growing pharmaceutical and medical device sectors, the animal model industry is expected to grow. As a result of increased government spending on the modernisation of healthcare facilities and increasing demand for advanced manufacturing technology, the health sector is growing in developing countries.

Animal Model Segmentation Analysis -

By Type
→Mice
→Rat
→Guinea Pigs
→Rabbits
→Hamsters
→Others

By Application
→Cancer
→Immunological Disease
→Infectious Disease
→Others

By End User
→Pharmaceutical & Biotechnology Companies
→Academic Research Institute
→Contract Research Organization

In 2022, the mice segment represented the highest revenue share of 52.7% and is expected to increase at an accelerated pace over the period 2023 to 2030. The growth of the segment is expected to be driven by factors, e.g. increased investment and technical progress in mouse model technologies. In addition, due to the increased impact of mouse clinical trials on more reliable results and a growing demand for personalised medicines, there is also an increasing need for mice models. In March 2023, researchers from the National Institutes of Health studied an enhanced version of a Down syndrome gene model in animals. In a new mouse model, potential therapeutic options for the treatment of this disease have been introduced.

In 2022, the cancer segment accounted for 43.0% of the application market and is expected to grow at a faster pace during the forecast period. Factors such as the translational importance of animal models in cancer research, an increasing trend towards precision oncology and development of tumour modelling techniques are expected to drive growth for this segment. Furthermore, animal models may assist researchers in assessing the therapeutic index, bioavailability and pharmacokinetics of anticancer medicinal products before moving to human clinical trials.

Animal Model Key Regional Development -

In 2022, The North American market represented 48,5 % of the worldwide market and is expected to continue growing steadily in the coming years. The region's development has been helped by the presence of high-profile players as well as a number of strategic initiatives undertaken by them. In addition, growing biomedical research and increasing investment in medical trials are contributing to market growth across the region. Advances in gene engineering and the growing adoption of animal derived models for drug profiling and characterisation studies are also expected to provide new opportunities for market growth.

The Asia Pacific region is expected to grow more quickly than the rest of the world. A high incidence of chronic diseases, such as cancer, immunological disorders and rare diseases, is expected to support the growth of the region's market. In addition, a significant investment by industry players in the region together with government support for research is another factor driving growth on this market.

Need Customized Report as per Your Business Requirement Ask Here @ https://www.snsinsider.com/enquiry/3789

Key Takeaway from Animal Model Market Study-

The growth of the worldwide animal model market is expected to be driven by a large number of applications in health care, as well as human physiology similarities with animals.

The market for animal models is expected to grow during the forecast period, driven by increased use of personalised medicine. In Singapore, such programs as the National Precision Medicine Program and Three Beyonds were initiated in order to encourage the use of new technologies and Digital Infrastructure with a view to supporting personalised medical care.

Recent Development Related to Animal Model Market -

In March 2022, A contract to breed, market and sell SRG rats to the world's preclinical research community has been signed between Charles River Laboratories and Hera Biolabs. Hera BioLabs aims to increase the geographical reach of its severely immunodeficient rat model by means of such a deliberate partnership.

In April 2022, Taconic Biosciences and BioModels have worked together to launch the Taconic Biosciences and BioModels Microbiome Initiative, providing investigators with complete germ free and gnotobiotic microbiome study solutions, from design to data. The solutions helps eliminate hurdles which have long limited microbiome research by combining access to relevant disease models, germ-free animal production, and downstream in-vivo research design, execution, and analytics.

Buy Animal Model Market Report @ https://www.snsinsider.com/checkout/3789

Table of Contents

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
5. Value Chain Analysis

6. Porter's 5 forces model

7. PEST Analysis

8. Animal Model Market Segmentation, By Animal Type
8.1 Mice
8.2 Rat
8.3 Guinea Pigs
8.4 Rabbits
8.5 Hamsters
8.6 Others

9. Animal Model Market Segmentation, By Application
9.1 Cancer
9.2 Immunological Disease
9.3 Infectious Disease
9.4 Others

10. Animal Model Market Segmentation, By End User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Academic Research Institute
10.3 Contract Research Organization

11. Regional Analysis

12. Company profile

13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.4. Industry News
13.5. Company News
13.6.Mergers & Acquisitions

14. Use Case and Best Practices

15. Conclusion

continued

Access Complete Report Details with Toc and Graphs@ https://www.snsinsider.com/reports/animal-model-market-3789

Contact Us:
Akash Anand - Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

This release was published on openPR.